Primary Antiphospholipid Syndrome

2

Review clinical trials related to Primary Antiphospholipid Syndrome. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases

Longitudinal prospective multicenter Armenian registry of systemic autoimmune, autoinflammatory diseases with constitution of bio-banking.

Participants needed: 800
Trial details
Biological sex: AllType: ObservationalSponsor: Santé Arménie French-Armenian Research CenterUpdated: Apr 8, 2025Locations: 6
Eligibility criteria

Age: major and minor [+1]

Patients refusing to participate in the registry [+2]

Status: Not yet recruiting

The Safety and Efficiency of Sirolimus in Primary Antiphospholipid Syndrome: a Randomized Control Study

This study is an Investigator initiated, randomized, multicenter, double-blind, placebo-control study. The aim of this study is to evaluate the safety and efficiency of Sirolimus for primaty antiphospholipid syndrome patients at week 24 and week 48.

Participants needed: 70
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Peking University People's HospitalUpdated: Sep 19, 2024
Eligibility criteria

Understand and sign the informed consent form [+4]

history of serious adverse events or contraindication to Sirolimus [+11]